[1] 曾民德. 非酒精性脂肪性肝病:回顾历史,展望未来. 实用肝脏病杂志,2016,19(2):129-131. [2] Mishra A,Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Rev Prat,2012,62(10):1420-1421. [3] Chalasani N,Younossi Z,Lavine J E,et al. The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology. Gastroenterology,2012,142(7):1592-1609. [4] 娜日苏,包纳日斯. 非酒精性脂肪肝的发病机制与流行病学的研究进展. 中国医药指南,2016,14(3):39-40. [5] Chalasani N,Younossi Z,Lavine JE,et al. The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American association for the study of liver diseases,American College of Gastroenterology,and the American Gastroenterological Association. Gastroenterology,2012,142(7):1592-1609. [6] 丁莺,曾蒙苏,饶圣祥,等. 肝细胞特异性对比剂钆塞酸二钠增强磁共振检查对非酒精性脂肪肝诊断及分级的潜在价值. 中华肝脏病杂志,2015,23(4):194-196. [7] Parker H M,Johnson N A,Burdon C A,et al. Omega-3 supplementation and non-alcoholic fatty liver disease:A systematic review and meta-analysis. J Hepatol,2012,56(4):944-951. [8] 宗湘裕,杜长海,刘宝珍,等. 非酒精性脂肪肝患者胰岛素抵抗、脂质代谢与中医证型的关系分析. 北京中医药,2012,31(7):493-495. [9] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南. 实用肝脏病杂志,2007,10(1):1-3. [10] 孙建光,吕霞霞. 非酒精性脂肪肝相关危险因素分析. 中医临床研究,2011,38(18):2231-2233. [11] Bhatia L S,Curzen N P,Calder P C,et al. Non-alcoholic fatty liver disease:a new and important cardiovascular risk factor. Eur Heart J,2012,33(10):1190-1200. [12] Musso G,Cassader M,Rosina F,et al. Impact of current treatments on liver disease,glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease(NAFLD):a systematic review and meta-analysis of randomised trials. Diabetologia,2012,55(4):885-904. [13] 储建坤,霍晓辉,马金城. 非酒精性脂肪肝中医症候分布特点及其相关Logistic因素分析. 中华中医药杂志,2013,9(6):1917-1919. [14] 李玛,陈忠城,黄建华,等. 总胆固醇、甘油三酯和胰岛素敏感指数对非酒精性脂肪肝诊断价值的比较. 中国卫生检验杂志,2013,12(10):2307-2310. [15] 苏如婷,韩晓骏. 非酒精性脂肪肝病与胰岛素抵抗的相关性. 实用医学杂志,2012,28(21):3551-3553. [16] 叶咸德. 老年非酒精性脂肪肝患者的血脂、脂蛋白和胱抑素C的水平变化. 中国老年学,2016,36(10):2438-2439. [17] Aron-Wisnewsky J,Gaborit,B,Dutour,A,et al. Gut microbiota and non-alcoholic fatty liver disease:new insights. Clin Microbiol Infect,2013,34(4):338-348. [18] 黄红革,宗彦红,赵晓云. 非酒精性脂肪肝生化指标分析. 河北医药,2013,35(7):1001-1002. [19] Salvatore P,Christiano A,Daniela C,et al. Epicardial fat,cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease:Association with the severity of liver disease. J Hepatol,2014,62(4):928-933. [20] 谢松生,钟万芬,李文郎,等. 8项生化指标对酒精性脂肪肝诊断的临床价值研究. 临床和实验医学杂志,2013,12(21):1752-1754. [21] 孙晓琦,方南元,薛博瑜. GGT与非酒精性脂肪肝及相关疾病的研究进展. 世界华人消化杂志,2014,35(31):4745-4749. |